Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-224545

Chief Financial Officer sold 17,717 shares at $12.86 ($227,841)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2026-05-14 Sale 10b5-1 −17,717 $12.86 $227,841 195,178 D: show line 1 in the form
Open-market sales · 17,717 sh · avg $12.86 · $227,841
Loading xslF345X06/ownership.xml…